• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Apremil
    / MAPI Pharma LTD, Israel


    Active Ingredient
    Apremilast 30 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    56 X 30 mg

    partial basket chart

    Dosage

    Please refer to the license holder for further details


    Indications

    For treatment of adult patients with active psoriatic arthritis (PsA).- For adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (PSOR).- For the treatment of adult patients with oral ulcers associated with Behçet’s disease (BD).


    Contra-Indications

    Hypersensitivity to the active substance(s) or to any of the excipients
    Pregnancy


    Special Precautions

    Please refer to the license holder for further details


    Side Effects

    Please refer to the license holder for further details


    Drug interactions

    Please refer to the license holder for further details


    Pregnancy and Lactation

    Please refer to the license holder for further details


    Overdose

    Please refer to the license holder for further details


    Manufacturer
    MAPI Pharma LTD, Israel

    סרגל נגישות

    CLOSE